
Tecartus FDA Approval: ZUMA-2 Data for Mantle Cell Lymphoma
Review the FDA full approval of Tecartus for relapsed mantle cell lymphoma. This analysis covers ZUMA-2 Cohort 3 efficacy data, CAR-T safety, and clinical use.

Review the FDA full approval of Tecartus for relapsed mantle cell lymphoma. This analysis covers ZUMA-2 Cohort 3 efficacy data, CAR-T safety, and clinical use.

Examine the FDA approval of Otarmeni, the first gene therapy for OTOF-related congenital hearing loss, and its expedited National Priority Voucher review.

A 2025 overview of AI in radiology, covering FDA approvals, clinical adoption rates, and key technologies from CNNs to foundation models for medical imaging.
© 2026 IntuitionLabs. All rights reserved.